These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 10688429)

  • 1. Eosinophil activation by eotaxin--eotaxin primes the production of reactive oxygen species from eosinophils.
    Honda K; Chihara J
    Allergy; 1999 Dec; 54(12):1262-9. PubMed ID: 10688429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of eotaxin on the generationof reactive oxygen species from eosinophil cell line, YY-1.
    Honda K; Yamada Y; Cui C; Saito N; Kayaba H; Kobayashi Y; Oyamada H; Kamada Y; Kuwasaki T; Tsurufuji S; Chihara J
    Int Arch Allergy Immunol; 1999; 120 Suppl 1():48-50. PubMed ID: 10529604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human eotaxin represents a potent activator of the respiratory burst of human eosinophils.
    Elsner J; Höchstetter R; Kimmig D; Kapp A
    Eur J Immunol; 1996 Aug; 26(8):1919-25. PubMed ID: 8765040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant human eotaxin induces oxygen radical production, Ca(2+)-mobilization, actin reorganization, and CD11b upregulation in human eosinophils via a pertussis toxin-sensitive heterotrimeric guanine nucleotide-binding protein.
    Tenscher K; Metzner B; Schöpf E; Norgauer J; Czech W
    Blood; 1996 Oct; 88(8):3195-9. PubMed ID: 8874220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priming effect of RANTES on eosinophil oxidative metabolism.
    Chihara J; Yamada H; Yamamoto T; Kurachi D; Hayashi-Kameda N; Honda K; Kayaba H; Urayama O
    Allergy; 1998 Dec; 53(12):1178-82. PubMed ID: 9930594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulated response to chemokines in oxidative metabolism of eosinophils in asthma and allergic rhinitis.
    Sannohe S; Adachi T; Hamada K; Honda K; Yamada Y; Saito N; Cui CH; Kayaba H; Ishikawa K; Chihara J
    Eur Respir J; 2003 Jun; 21(6):925-31. PubMed ID: 12797483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RANTES augments eosinophil lucigenin-dependent chemiluminescence.
    Chihara J; Kakazu T; Higashimoto I; Saito N; Honda K; Tsuda A; Kayaba H; Kamada Y; Oyamada H; Urayama O
    Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():40-3. PubMed ID: 9758895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chemokine RANTES is more than a chemoattractant: characterization of its effect on human eosinophil oxidative metabolism and morphology in comparison with IL-5 and GM-CSF.
    Kapp A; Zeck-Kapp G; Czech W; Schöpf E
    J Invest Dermatol; 1994 Jun; 102(6):906-14. PubMed ID: 7516398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eotaxin-2 activates chemotaxis-related events and release of reactive oxygen species via pertussis toxin-sensitive G proteins in human eosinophils.
    Elsner J; Petering H; Kluthe C; Kimmig D; Smolarski R; Ponath P; Kapp A
    Eur J Immunol; 1998 Jul; 28(7):2152-8. PubMed ID: 9692884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ketotifen on the production of reactive oxygen species from human eosinophils primed by eotaxin.
    Yamada Y; Sannohe S; Saito N; Cui CH; Ueki S; Oyamada H; Kanda A; Yamaguchi K; Hamada K; Adachi T; Kayaba H; Chihara J
    Pharmacology; 2003 Nov; 69(3):138-41. PubMed ID: 14512700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminooxypentane-RANTES induces CCR3 activation and internalization of CCR3 from the surface of human eosinophils.
    Elsner J; Dulkys Y; Kimmig D; Wells TN; Proudfoot AE; Kapp A
    Int Arch Allergy Immunol; 2001; 124(1-3):227-9. PubMed ID: 11306977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils.
    El-Shazly A; Masuyama K; Nakano K; Eura M; Samejima Y; Ishikawa T
    Int Arch Allergy Immunol; 1998 Sep; 117 Suppl 1():55-8. PubMed ID: 9758899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of ketotifen on eotaxin-dependent activation of eosinophils: consequences for allergic eye diseases.
    Woerly G; Loiseau S; Loyens M; Schoch C; Capron M
    Allergy; 2003 May; 58(5):397-406. PubMed ID: 12752326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible involvement of C-C chemokines in functional augmentation of adhesion molecules in asthmatic patients.
    Saito N; Yamada Y; Sannohe S; Honda K; Adachi T; Kayaba H; Chihara J
    Lung; 2002; 180(5):251-63. PubMed ID: 12489019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.
    Rothenberg ME; Ownbey R; Mehlhop PD; Loiselle PM; van de Rijn M; Bonventre JV; Oettgen HC; Leder P; Luster AD
    Mol Med; 1996 May; 2(3):334-48. PubMed ID: 8784786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
    Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines.
    Shahabuddin S; Ponath P; Schleimer RP
    J Immunol; 2000 Apr; 164(7):3847-54. PubMed ID: 10725746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-16 promotes leukotriene C(4) and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling.
    Bandeira-Melo C; Sugiyama K; Woods LJ; Phoofolo M; Center DM; Cruikshank WW; Weller PF
    J Immunol; 2002 May; 168(9):4756-63. PubMed ID: 11971026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin.
    Penido C; Castro-Faria-Neto HC; Vieira-de-Abreu A; Figueiredo RT; Pelled A; Martins MA; Jose PJ; Williams TJ; Bozza PT
    Am J Respir Cell Mol Biol; 2001 Dec; 25(6):707-16. PubMed ID: 11726396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of roxithromycin on eotaxin-primed reactive oxygen species from eosinophils.
    Cui CH; Honda K; Saito N; Yamada Y; Sannohe S; Ueki S; Hamada K; Yamaguchi K; Kobayashi Y; Adachi T; Kayaba H; Chihara J
    Int Arch Allergy Immunol; 2001; 125 Suppl 1():38-41. PubMed ID: 11408771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.